Estradiol lingual spray - NovaDel

Drug Profile

Estradiol lingual spray - NovaDel

Latest Information Update: 11 Feb 2008

Price : $50

At a glance

  • Originator NovaDel Pharma
  • Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Menstrual migraine; Vasomotor symptoms

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 11 Feb 2008 Discontinued - Phase-II for Menstrual migraine in USA (Transmucosal)
  • 11 Feb 2008 Discontinued - Phase-II for Vasomotor symptoms in USA (Transmucosal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top